Zoetis Inc (ZTS) support and resistance · P/E 25, rev $2.47B
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
This page maps Zoetis Inc (ZTS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
ZTS currently screens at market cap $64.65B and trailing P/E 24.9. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new ZTS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the ZTS quote page for the session range and the stock page for the full model.
Not investment advice.